Fundz

Atavistik Bio Appoints Susan Pandya as Chief Medical Officer

PRIVATESep 15, 2025

Position

Chief Medical Officer

Company

Atavistik Bio

Susan Pandya
susanpandya@atavistikbio.com
CambridgeBiotechnologySoftwareHealth CareScience And Engineering

Description

Atavistik Bio has announced the appointment of Susan Pandya, M.D., as Chief Medical Officer. Dr. Pandya brings extensive drug development experience and will lead clinical development strategy and execution for the company.

Quick answer

Atavistik Bio Appoints Susan Pandya as Chief Medical Officer (September 15, 2025). Atavistik Bio is based in Cambridge, Massachusetts, United States.

Who is the new Chief Medical Officer at Atavistik Bio?
Atavistik Bio named Susan Pandya Chief Medical Officer, announced September 15, 2025.
What did Atavistik Bio announce on September 15, 2025?
Atavistik Bio has announced the appointment of Susan Pandya, M.D., as Chief Medical Officer. Dr. Pandya brings extensive drug development experience and will lead clinical development strategy and execution for the company.
What does Atavistik Bio do?
Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology.
Where is Atavistik Bio based?
Atavistik Bio is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
RegASK (September 23, 2025), Check Point (September 4, 2025), Psilera (September 4, 2025) and Nomad Power Solutions, Inc. (September 3, 2025) also announced leadership changes within 45 days of Atavistik Bio.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Atavistik Bio, and when

A new leader at Atavistik Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Atavistik Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Atavistik Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Atavistik Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Atavistik Bio

Location

Cambridge, Massachusetts, United States

About

Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology. Since its inception, Atavistik Bio has rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. ATV-1601, a selective allosteric inhibitor for solid tumors, is anticipated to enter the clinic in early 2025. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, and Lux Capital.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Atavistik Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bryan
Likely contact at this company
••••••••@••••••••

See Bryan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Atavistik Bio's next move

Learn about Strategic plan

Atavistik Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.